PRECLINICAL DEVELOPMENT OF EPIREADY, A NOVEL THERAPEUTIC TO TREAT NONHEALING DIABETIC FOOT ULCERS

$1,698,207FY2016Department of the ArmyDOD

Stratatech Corporation, Hazelwood WI

Investigators